Physician profile
Trew J Stransky
NPI 1699785584
$1,098.91
in general payments reported to CMS, 2019-2025
18 companies · $389 in 2025
The $389 reported for 2025 was more than what 88% of Adolescent Medicine (Pediatrics) providers received nationally (typical 2025 total: $99.31).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $79.93 · 2020: $73.01 · 2021: $237 · 2022: $108 · 2023: $99.13 · 2024: $113 · 2025: $389.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $601.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $601.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $153.45 | 2021-2025 | Gardasil 9, Vaxneuvance, Vaxelis |
| Supernus Pharmaceuticals, INC. | $137.97 | 2023-2025 | Qelbree, Qelbree |
| Takeda Pharmaceuticals U.S.A., INC. | $126.55 | 2020-2021 | |
| Sanofi Pasteur INC. | $82.63 | 2019-2024 | |
| Cranial Technologies, INC | $74.20 | 2022-2025 | Doc Band |
| Pfizer INC. | $73.09 | 2022-2025 | |
| Corium, LLC | $64.42 | 2025 | Azstarys |
| Kaleo, INC. | $62.29 | 2019-2021 | |
| Collegium Pharmaceutical, INC. | $62.18 | 2025 | Jornay Pm |
| Phadia US INC. | $53.40 | 2020-2021 | |
| Ars Pharmaceuticals Operations, INC. | $45.33 | 2025 | Neffy |
| Seqirus USA INC | $37.61 | 2021-2025 | Flucelvax |
| Sanofi-Aventis U.S. LLC | $31.96 | 2025 | |
| Ironshore Pharmaceuticals INC. | $27.80 | 2019 | |
| Cognoa, INC. | $23.80 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $15.85 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $14.65 | 2025 | Zoryve |
| Shire North American Group INC | $11.73 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Trew Stransky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.